|
![]() |
Equipments |
|
NanoLC-MS/MS strategies contributed a lot to the progress in high-throughput
protein identification. Proteomics has then turned quantitative to
address major issues in biology, like understanding the effect of
various stimuli and drug treatment on cellular processes at the
protein level, or discover new biomarkers in clinical applications.
The development of these quantitative proteomic strategies have been
so far successful thanks to improved mass spectrometers capabilities
(high resolution, high acquisition speed, high sensitivity) and to
new bioinformatic tools, and should develop further in the coming
years. Mass spectrometers:
The acquisition of the nanoLC-ESI-LTQ-Orbitrap (October 2006)
improved considerably the analytical capabilities of the Proteomics
Platform and allowed the development of new research programs, in
particular in quantitative proteomics and in the identification of
low-abundance proteins. Separating techniques and robots:
Biomolecular interaction analysis:
Informatics and Bioinformatics:
|